EyeGene Inc. (KOSDAQ:185490)
South Korea · Delayed Price · Currency is KRW 1,952.00
+2.00 (0.10%)
At close: Dec 5, 2025
EyeGene Revenue
EyeGene had revenue of 1.10B KRW in the quarter ending September 30, 2025, with 14.36% growth. This brings the company's revenue in the last twelve months to 4.10B, up 25.97% year-over-year. In the year 2024, EyeGene had annual revenue of 3.36B with 7.37% growth.
Revenue (ttm)
4.10B
Revenue Growth
+25.97%
P/S Ratio
12.86
Revenue / Employee
n/a
Employees
n/a
Market Cap
52.76B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 3.36B | 230.37M | 7.37% |
| Dec 31, 2023 | 3.13B | -2.17B | -40.96% |
| Dec 31, 2022 | 5.29B | 2.05B | 63.27% |
| Dec 31, 2021 | 3.24B | -121.31M | -3.61% |
| Dec 31, 2020 | 3.36B | -881.96M | -20.77% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Samsung Electronics | 315.56T |
| Hyundai Motor Company | 186.04T |
| Kia Corporation | 113.20T |
| SK hynix | 84.09T |
| LG Energy Solution | 23.98T |
| Hanwha Aerospace | 23.11T |
| Doosan Enerbility | 16.79T |
| HD Hyundai Heavy Industries | 16.39T |